DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
-1.96%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$114M
AUM Growth
+$114M
Cap. Flow
-$23.8M
Cap. Flow %
-20.92%
Top 10 Hldgs %
42.25%
Holding
85
New
11
Increased
13
Reduced
18
Closed
19
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CDTX icon
26
Cidara Therapeutics
CDTX
$1.61B
$1.66M 1.46%
+7,996
New +$1.66M
SPNC
27
DELISTED
Spectranetics Corp
SPNC
$1.61M 1.41%
65,496
TNDM icon
28
Tandem Diabetes Care
TNDM
$834M
$1.56M 1.37%
72,429
SYRE icon
29
Spyre Therapeutics
SYRE
$1.02B
$1.52M 1.34%
14,016
RCKT icon
30
Rocket Pharmaceuticals
RCKT
$358M
$1.45M 1.27%
59,284
-25
-0% -$610
ADXS
31
DELISTED
Advaxis, Inc.
ADXS
$1.25M 1.1%
+11,667
New +$1.25M
QURE icon
32
uniQure
QURE
$954M
$1.14M 1%
203,907
JNJ icon
33
Johnson & Johnson
JNJ
$429B
$1.08M 0.95%
9,400
ASND icon
34
Ascendis Pharma
ASND
$12.1B
$1.07M 0.94%
53,000
+22,250
+72% +$450K
PTGX icon
35
Protagonist Therapeutics
PTGX
$3.62B
$1M 0.88%
45,586
-78,218
-63% -$1.72M
ZGNX
36
DELISTED
Zogenix, Inc.
ZGNX
$906K 0.8%
74,538
-5,000
-6% -$60.8K
STXS icon
37
Stereotaxis
STXS
$246M
$892K 0.78%
1,372,862
EXAC
38
DELISTED
Exactech Inc
EXAC
$864K 0.76%
31,636
ARQL
39
DELISTED
Arqule Inc
ARQL
$843K 0.74%
+668,735
New +$843K
NDRM
40
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$842K 0.74%
37,921
+23,500
+163% +$522K
ACHN
41
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$812K 0.71%
196,500
+10,000
+5% +$41.3K
NVDQ
42
DELISTED
Novadaq Technologies Inc.
NVDQ
$722K 0.63%
101,841
ELOS
43
DELISTED
Syneron Medical Ltd
ELOS
$722K 0.63%
85,947
CGNT
44
DELISTED
Cogentix Medical, Inc.
CGNT
$710K 0.62%
353,482
CNCE
45
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$689K 0.61%
66,968
MASI icon
46
Masimo
MASI
$7.43B
$674K 0.59%
10,000
ABUS icon
47
Arbutus Biopharma
ABUS
$753M
$573K 0.5%
+234,000
New +$573K
BLUE
48
DELISTED
bluebird bio
BLUE
$555K 0.49%
695
+232
+50% +$185K
SCYX icon
49
SCYNEXIS
SCYX
$35.2M
$554K 0.49%
17,365
-3,960
-19% -$126K
EIGR
50
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$468K 0.41%
1,340
-1,660
-55% -$580K